DNA Today: A Genetics Podcast

What does Fabry disease really look like across patients—and why is it so often misunderstood? In this episode of DNA Today, we’re taking a deep dive into Fabry disease, a rare X-linked lysosomal storage disorder with highly variable presentations, especially between genders.

Joining us is Dr. Amy Kritzer, a clinical geneticist and a leading expert in metabolic disorders in Boston, Massachusetts. We explore why the “carrier” label doesn’t apply to females, the challenges of delayed diagnosis, and the importance of cascade screening for families.

We want to thank Amicus Therapeutics for sponsoring this episode and point out that our conversation is intended for U.S. healthcare professionals. 

Topics Covered in This Episode

What Fabry disease is and how it affects the body.

The impact of Fabry’s X-linked inheritance on clinical presentation.

Why the term “just a carrier” is misleading for females or people with two X chromosomes.

Variability in disease expression among females and key clinical cases.

Classic vs. later-onset Fabry phenotypes and diagnostic challenges.

Common signs and symptoms that often go unrecognized.

Barriers leading to delayed diagnosis and under-recognition.

Benefits of early detection and cascade family screening.

Managing variants of uncertain significance (VUS) in the GLA gene.

Limits of genotype–phenotype correlations in Fabry disease.

Psychosocial challenges for families living with a Fabry diagnosis.

Advice for clinicians and genetic counselors evaluating potential Fabry patients.

Resources & Links

The brand new website, FindingFabry.com has additional information and resources. 

Amicus’ website here also has information about Fabry disease. 

Patients’ stories about living with Fabry disease. 

Get ready, genetic nerds—another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday. 

While you wait, why not dive into our library of over 375 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen—just search “DNA Today.”

Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel! 

DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead is Kajal Patel. Our Outreach Intern is Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC. 

See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to [email protected].

What drives scientific discovery, and how do those discoveries evolve into treatments that transform lives?

In this in-person episode of DNA Today, we’re exploring the human side of science: the curiosity, collaboration, and persistence that fuel discovery. This episode is part of a special partnership with The Advanced Portfolio from Wiley, a collection of world-leading scientific journals bridging disciplines to accelerate progress in biology, genetics, and medicine.

We’re joined by two guests whose careers beautifully reflect the bridge between innovation and impact:

Dr. Elizabeth Bhoj is an attending physician and researcher at the Children’s Hospital of Philadelphia and an assistant professor at the University of Pennsylvania’s Perelman School of Medicine. Her work focuses on discovering new genetic disorders, understanding how they work, and developing targeted therapies, bringing hope to families facing rare diseases. At the conference, she was the recipient of the ASHG Early Career Award, recognizing her extraordinary contributions to human genetics.

Dr. Yuming Hu is a scientist turned publisher who serves as part of the editorial leadership at Wiley’s Advanced Portfolio. She has ten years of research experience, focusing on plant biology and environmental sciences. Before joining Wiley in 2022, she worked as a postdoctoral researcher at Tsinghua University, China. She had also worked as a research assistant at the University of California, Davis. Yuming obtained her Ph.D. in biochemistry and biotechnology from Ghent University, Belgium. She studied biotechnology, and got her M.Sc. and B.Sc. degrees from Wageningen University, the Netherlands. Yuming brings a global and cross-disciplinary perspective to how research is shared, discovered, and amplified.

Topics Covered In This Episode: 

The stories behind scientific breakthroughs and what fuels discovery

How collaboration across disciplines accelerates innovation

Translating genetic discoveries into real-world therapies

The role of publishing and open science in driving progress

How journals are adapting to promote transparency and reproducibility

Advice for early-career researchers balancing ambition with sustainability

The evolving landscape of global collaboration in science

How AI and automation are transforming both research and publishing

The ethics and equity considerations of AI-driven science

The importance of representation and global voices in genomics

Key Takeaways

True innovation thrives on collaboration—across labs, disciplines, and continents.

Publishing isn’t the end of science; it’s a catalyst for connection and progress.
Bridging basic discovery to clinical application requires persistence and shared purpose.

Transparency, communication, and mentorship are essential to the next wave of breakthroughs.

Relevant Resources: 

Wiley Advanced Portfolio 

Wiley’s Journal Finder

Genetics and Genomics: Advanced Science Collection 

Precision medicine: From new tools to innovative applications: Advanced Portfolio Cross-journal Collections

Wiley's AI guidelines for Authors

Wiley’s ExplanAItions 2025: The evolution of AI in research

What Makes a Successful Submission Wiley Blog Post

Eligibility for access to Research4Life 

Wiley Announce Team of Editors to Lead Advanced Portfolio Journals Expansion into Life Health Sciences

Wiley Expands Advanced Journal Portfolio into Life and Health Sciences Deepens Physical Science Offering

 

Relevant DNA Today Podcast Episode:

#337 How to Get Your Research Published: Insight from Wiley’s Advanced Portfolio Journal Editors

#345 How To Talk About DNA Without Losing People: Strategies Part 1

#350 How To Talk About DNA Without Losing People: Strategies Part 2

#363 ASHG 2025 Recap: AI Diagnostics, Genetics Publications & Losing NIH Funding (Drs. Bhoj and Hu were also guests) 

 

Connect With Us: 

Get ready, genetic nerds, another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday. 

While you wait, why not dive into our library of over 375 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen, search “DNA Today.”

Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel! 

DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC. 

See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to [email protected].

What if we looked at genetic testing not just as a tool, but as a story unfolding through eras of innovation, access, and personal meaning? 

To explore the genetic testing landscape over the last couple decades we are joined by a fellow podcaster Rome Madison, who is also a precision medicine expert and longtime industry leader with extensive experience working in diagnostics and precision medicine. 

Rome has trained sales teams, helped launch groundbreaking cancer diagnostics, and now hosts Genetics for Healthcare: A Podcast for Patients. He’s here to share not only how genetic testing has evolved across different eras, but also his personal connection to the field and why he’s committed to ensuring patients benefit from the genomic revolution.

 

On This Episode, We Discuss:

 

Setting the Stage: Rome’s Personal Journey

How Rome entered the genetics and diagnostics space shortly after the Human Genome Project

What motivates his continued work at the intersection of innovation, patients, and access

Why confidence, curiosity, and communication matter in fast-changing scientific fields

The Early Era: Post–Human Genome Project

What diagnostics felt like in the early 2000s

Early pharmacogenomics and predicting chemotherapy response

Barriers to adoption, including cost, infrastructure, and skepticism

The Growth Era: Expansion of Genetic Testing

How cancer diagnostics and precision medicine began shaping standard care

Shifts in how clinicians and patients talked about risk and prevention

Lessons learned about equity, access, and unmet expectations

The Current Era: Precision Medicine Goes Mainstream

What distinguishes today’s genetic testing landscape from earlier eras

Ongoing challenges around affordability, access, and education

The role of podcasts and science communication in empowering patients

Looking Ahead: The Next Era of Genetic Testing

What might define the next wave: RNA, epigenomics, microbiome, multi-omics

Where AI and advanced data analytics fit into future care models

Why collaboration across pharma, diagnostics, advocacy groups, and patients is essential

Whether population-wide genetic testing could become routine in the years ahead

 

About the Guest
Rome Madison helps people and organizations in the life science industry increase confidence, embrace uncertainty and navigate chaos to rise and win in the market. With over 20 years of experience leading sales teams and go-to market strategy for successful start-ups and new products, Rome has Unreasonable Confidence that cancer and other chronic genetic diseases can be prevented, detected early, treated effectively and cured.

 

Rome has given more than 500 live speeches and is a charismatic virtual presenter that keeps your audience glued to the screen and engaged with his content. He has appeared on more than 50 TV and radio shows across the US as a precision medicine expert, and has been a featured speaker at the Consumer Electronics Show on The Future of Healthcare.

 

Rome’s podcast, Genetics for Healthcare: A Podcast for Patients, unites major healthcare stakeholders to close the gap of innovation and patient access to precision medicine. He is co-creator and host of the award-winning Precision Medicine Podcast, Google’s #1 rated podcast on the topic of next-generation cancer care, with listeners in over 108 countries.

Relevant Resources: 

Genetics for Healthcare Podcast Hosted by Rome Madison 

American Lung Association; EGFR and Lung Cancer 

Breast Cancer Research Foundation; HER2-Positive Breast Cancer: Testing, Treatment, Research

Fierce Biotech; Labcorp picks up Invitae portfolio for $239M in bankruptcy sale

The Guardian; 23andMe’s founder wins bid to regain control of bankrupt DNA testing firm

National Comprehensive Cancer Network Guidelines 

The Patient Will See You Now Book by Dr. Eric Topol (Kira was right, it was published 10 years ago!)

 

Relevant DNA Today Podcast Episode:

#145 Greenwood Genetic Center on Epigenetics

#182 Eric Green on the Complete Human Genome Project 

#358 AGBT Precision Health 2025 Meeting Recaps and Reflections

#361 The Economics of Genetic Counseling: Policy, Industry & Career Advice

#362 Optical Genome Mapping: Detecting Structural Variants Missed by Traditional Tests

#363 ASHG 2025 Recap: AI Diagnostics, Genetics Publications & Losing NIH Funding

#364 Breast Cancer Genetic Testing in Italy: A Curated Gene Panel

#370 Genetics Wrapped: 2025 Top Advances in Genomic Medicine

Get ready, genetic nerds, another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday. 

While you wait, why not dive into our library of over 370 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen, just search “DNA Today.”

Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel! 

DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC. 

See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to [email protected].

This is our sixth installment in our Mock Genetic Counseling Session Series! In this episode, genetic counselor Charlotte Close and student Marcely Ventura perform a mock genetic counseling session. The session indication is an abnormal newborn screening result for cystic fibrosis. 

 

This session was recorded in-person, providing a more dynamic and engaging learning experience therefore, we highly recommend watching it on YouTube to fully immerse yourself in the interaction. 

 

We hope this series is helpful for prospective and current genetic counseling students, as well as the general public, by demystifying the genetic counseling process. Understanding how these sessions work can empower individuals and provide valuable educational insights into this critical healthcare service.

The Actors:
Marcely Ventura (she/her) is currently in her second and final year in the Human Genetics Program at Sarah Lawrence College training to be a genetic counselor. Ventura is a graduate of Hunter College with a B.A. in Human Biology. Ventura is the first recipient of the Lauren Ryan Genetic Counselor Access Memorial Award. This award celebrates Lauren Ryan’s legacy of advancing equity in genetic counseling and supports students from underrepresented communities. As a first-generation Hispanic college graduate, she is passionate about increasing access to genetic counseling for diverse communities and addressing health disparities. The premise of this mock case was part of her internship with DNA Today.  

 

Charlotte Close, MS, CGC (she/her) is a certified genetic counselor in the Division of Clinical Genetics at Columbia University Irving Medical Center (CUIMC) and a member of the multidisciplinary cystic fibrosis care team at CUIMC. She is passionate about improving access to genetic counseling services and has worked with the Cystic Fibrosis Foundation, other cystic fibrosis genetic counselors, and cystic fibrosis care team members from across the country to achieve this goal through policy changes, service delivery innovation, and educational efforts. In addition to her clinical work, Close contributes to the Graduate Program in Genetic Counseling at Columbia University by supervising students, mentoring research projects, and serving as a course director. She also serves as a Director on the New York State Genetics Taskforce. She received her Bachelor of Science in Microbiology from the University of Michigan and her Master of Science in Human Genetics from Sarah Lawrence College. 

 

Mock Session Information:
Session Indication: The patient is a 10 week old male with a positive newborn screen for cystic fibrosis who was referred to the genetics center by his pediatrician for further evaluation and discussion of genetic testing. The patient’s mother, Mary, is attending the appointment. 

Case Details:

The patient is a 10 week old male with a positive newborn screen for cystic fibrosis who was referred to the genetics center by his pediatrician for further evaluation and discussion of genetic testing.

 

Patient Name: Liam Ventura 

Parent Names: Mary and Sam Ventura

 

Medical History:

Pregnancy:
Uncomplicated

Full term (39 wks) via NSVD

No exposures or complications reported

Normal prenatal ultrasounds

Newborn Screening:
Elevated immunoreactive trypsinogen (IRT)

Two CFTR variants identified on screening panel

Development: Appropriate for age

Growth: Slightly below weight percentile

Symptoms: Mild cough, parents believe it’s due to the change of weather

Specialists Seen: Pediatrician only so far

Medications/Treatments: None currently

Therapies: None currently

Family History:

Ancestry: Dad- Irish  Mom- Af. American

No consanguinity, birth defects, or known genetic conditions

No history of cystic fibrosis or early infant deaths

One paternal cousin with male infertility

 

Prior Carrier Results: 

Dad- F508del Carrier 

Mom- Negative …. After first visit with Multidisciplinary team following variant is identified: c.1675G>A p.A559T 

 

Pediatric Mock Session Outline

 

Contracting

Greetings and introductions

Reason for referral to genetic counseling (positive newborn screening for CF)

Overview of session and what will be discussed: “I’m going to ask a lot of questions about when Liam was in your belly, up until now, as well as medical and family history questions just to make sure we have a full picture and aren’t missing anything. After that Dr.X will come in and do a physical/sweat test on Liam and we can talk about genetic testing options, how does that sound/any questions before we get started?” 

 

Address patient questions or concerns such as:
“What does this mean for our baby?”

“Does this mean he has cystic fibrosis?”

“Could this happen again in another pregnancy?”

“Did we do something to cause this?”

Medical Intake

Review pregnancy and delivery history

Review newborn history

Review of systems with focus on:
Respiratory symptoms

Digestive symptoms and growth patterns

Frequency of infections

Developmental milestones and any delays noted by parents

Medications, supplements, or current therapies

 

Family History

Construct a three-generation pedigree

Ask about consanguinity, early childhood deaths, chronic respiratory or digestive issues, and male infertility

Determine if any relatives have known carrier status for CF or other genetic conditions

Patient Education:

Overview of Genetics

Explanation of autosomal recessive inheritance

Each parent is likely a carrier of one CFTR gene variant

With each pregnancy:
25% chance for a child with CF

50% chance to be a carrier

25% chance to be unaffected and not a carrier

Cystic Fibrosis Overview

Genetic condition that can affect the lungs and digestive system

Caused by variants in the CFTR gene that affect how mucus and other secretions function

Range of possible symptoms from mild to more significant depending on variants involved (explain variable expressivity)

Genetic Testing Discussion

Both parents previously had carrier testing done, dad came back with a variant and mom did not. 

Testing options: 
CFTR gene sequencing and deletion/duplication analysis for mom: c.1675G>A p.A559T variant is found afterwards

Sample collection: Blood or saliva

Results:
Positive: Confirms CF diagnosis 

Testing Process

Turnaround time: 2–4 weeks

Informed consent and shared decision-making

Recommendations and Next Steps

Proceed with diagnostic testing for Liam

Offer CFTR gene sequencing to parents

Coordinate follow-up once results are available, will call once results are available

Provide educational resources on CF and genetic testing

Discuss implications for future pregnancies

 
Relevant Cystic Fibrosis Genetic DNA Today Episodes:
#147 CF Series: Bijal Trivedi on "Breath From Salt"

#148 CF Series: Shuling Guo on Pharmaceuticals

#149 CF Series: Boomer Esiason’s Son Gunnar on Patient Advocacy

 

Previous installments of our Mock Genetic Counseling Session series:
Episode #311: Cancer Session for Breast and Prostate Cancer Family History

Episode #317: Prenatal Session for Advanced Maternal Age

Episode #331: Pediatric Session for Autism

Episode #351: Cardio Session for Sudden Death of A Family Member 

Episode #368: Prenatal Session for Increased Nuchal Transluency 

Disclaimer:
Please note that the information provided in this mock genetic counseling session is intended strictly for educational purposes and should not be used for personal medical decision-making. If you have questions or concerns about your health, we encourage you to consult directly with a certified genetic counselor who can provide tailored medical recommendations. If you are in the United States, you can find a genetic counselor near you by visiting FindAGeneticCounselor.com. Stay tuned for an international genetic provider directory. 

 

Connect With Us:
Get ready, genetic nerds—another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday. 

While you wait, why not dive into our library of over 370 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen—just search “DNA Today.”

Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel! 

DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC. 

See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to [email protected].

What do you do when your family is faced with a rare disease that has no cure, and every day truly matters?

In this episode of DNA Today, we focus on Hunter syndrome (MPS II), a rare, progressive genetic condition that primarily affects children and leads to serious physical, neurological, and developmental challenges over time.

Our guest is Kristin McKay, Executive Director of Project Alive, a nonprofit organization dedicated to accelerating treatments, expanding access to care, and supporting families impacted by Hunter syndrome. Kristin’s advocacy is deeply personal: she lost her brother, Zachary, to Hunter syndrome, and today her son, Charlie, is living with the condition.

Kristin joins us to share what Hunter syndrome is, how it progresses, and how her family’s journey shaped her leadership and advocacy. We discuss the urgent need for effective treatments, the promise and uncertainty surrounding emerging gene therapies, and what families experience when regulatory delays impact a disease where time is not a luxury.

This conversation highlights both the science behind Hunter syndrome and the human cost of delay, along with the resilience of a community that continues to push forward fueled by hope.

On This Episode, We Discuss:

 

Understanding Hunter Syndrome (MPS II)
What it means to have a metabolic disorder and how MPS II affects the body

Common symptoms and how the disease progresses over time

The variability in presentation and severity among individuals

A Family’s Journey Through Hunter Syndrome
Kristin’s experiences growing up with a brother affected by Hunter syndrome

Losing Zachary and later receiving the diagnosis for her son, Charlie

How these experiences shaped her perspective as both a parent and an advocate

Project Alive: Mission, Growth & Impact
The origins and mission of Project Alive

Key initiatives supporting research, families, and advocacy

How the organization balances funding science, supporting families, and influencing policy

Gene Therapy & the RGX-121 Delay
Why RGX-121 is considered a promising potential one-time gene therapy for Hunter syndrome

What the FDA’s Prescription Drug User Fee Act (PDUFA) date extension means for patients and families

The emotional and practical impact of regulatory delays in ultra-rare diseases

What changes could help expedite review processes for rare disease therapies

Advocacy, Equity & Access
How Project Alive amplifies the voices of a small but urgent patient community

Strategies for engaging policymakers and industry partners

Lessons the broader rare disease field can learn from this advocacy model

Looking Ahead & How You Can Help
What listeners can do to support Project Alive

Opportunities for advocacy, awareness-building, and community engagement

Relevant Resources: 

Project Alive

MedlinePlus’ Mucopolysaccharidosis type II (Hunter syndrome) Page

The Orphan Drug Act 1983 strongly influenced by The National Organization for Rare Disorders (NORD)

Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision

FDA pushes back PDUFA date for Regenxbio's Hunter syndrome gene therapy

JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

FDA News Release: FDA Advances Rare Disease Drug Development with New Evidence Principles

Morimoto H, Morioka H, Imakiire A, Yamamoto R, Hirato T, Sonoda H, Minami K. Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice. Mol Ther Methods Clin Dev. 2022 May 10;25:534-544. doi: 10.1016/j.omtm.2022.05.002. PMID: 35662814; PMCID: PMC9142692.

The Precision Medicine Initiative launched by President Obama 

It Happened To Me Podcast Episode #16 ALS with Brook Eby (Kira referred to this being a DNA Today episode, she misremembered doing an episode drop on DNA Today, but maybe that means we should in the future) 

National Organization For Rare Disorders (NORD)

EveryLife Foundation For Rare Diseases

STAT News: 1 in 10 Americans have a rare disease, but few have treatments

Cystic Fibrosis Foundation’s Venture Philanthropy Model

Kim, Esther and Lo, Andrew W., Venture Philanthropy: A Case Study of the Cystic Fibrosis Foundation (April 23, 2019). Available at SSRN: https://ssrn.com/abstract=3376673 or http://dx.doi.org/10.2139/ssrn.3376673

Denali Therapeutics Drug Pipelines (including MPSII) 

Researchers estimated that 42% of Americans over age 55 will eventually develop dementia. 

NIH research (lead by Dr. Francis Collins) leads to first FDA-approved treatment for progeria

 

Relevant DNA Today Podcast Episode:

#147 CF Series: Bijal Trivedi on "Breath From Salt"

#149 CF Series: Gunnar Esiason on Patient Advocacy

#288 CRISPR Cured Victoria Gray’s Sickle Cell: Part 1

#289 CRISPR Cured Victoria Gray’s Sickle Cell: Part 2

#306 NIH’s Dr. Francis Collins’ Leadership in the Human Genome Project and COVID-19

#327 How Patient Advocacy is Changing Rare Disease Research

#332 Building Stronger Rare Disease Organizations: NORD CEO’s Insight

#356 From Statehouse to Capitol Hill: A Guide to Effective Advocacy for Rare Diseases

#370 Genetics Wrapped: 2025 Top Advances in Genomic Medicine

#371 Growing Old Too Fast: A Mother’s Fight for Cockayne Syndrome Advocacy

Get ready, genetic nerds, another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday. 

While you wait, why not dive into our library of over 370 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen, search “DNA Today.”

Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel! 

DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC.

See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to [email protected].